Frequency Of Depression In Patients Research Articles

Frequency of Depression in Patients Undergoing Coronary Artery Bypass Grafting Surgery (CABGS), Before the Surgery, at Discharge and at Six Months Follow up

Frequency of Depression in Patients Undergoing Coronary Artery Bypass Grafting Surgery (CABGS), Before the Surgery, at Discharge and at Six Months Follow up

Frequency of Depression in Patients with Migraine Presenting to Services Hospital Lahore

Objective: To determine the frequency of depression in patients with migraine coming to Services Hospital, Lahore. Methods: One hundred and fifty cases fulfilling the inclusion/exclusion criteria were enrolled in the study and informed consent was taken, regarding inclusion of patient in study. All patients after confirmation of migraine with consultant having at least 5 years of experience of consultancy, depression were evaluated by the researchers themselves. Results: Frequency of depression in patients with migraine coming to services hospital, Lahore was recorded in 48 %( n=72) while 52 %( n=78) had no findings of the morbidity. Conclusion: We concluded that the frequency of depression is high among patients with migraine. So, it is recommended that every patient who present with migraine, should be sort out for psychological disturbance

Depression in a Real World Population of Hepatitis C Patients

There is evidence as to the neurocognitive effects of the hepatitis C virus (HCV). In particular, depression is often identified in patients with HCV. Most studies reporting depression rates in HCV populations are in veterans’ populations or as part of therapeutic research trials, which represent quite selective populations. In a pilot study, we aimed to determine the frequency of depression in patients with hepatitis C virus infection attending a liver clinic in Australia. We investigated the records of 100 consecutive HCV patients, documenting an overall rate of depression of 29%, with 19% on antidepressant medications. A history of intravenous drug use was significantly associated with depression (RR) 2.2 (95%CI: 1.1-4.4). A history of depression was a significant predictor of depression on treatment with interferon based hepatitis C treatments (p = 0.01). Depression is a significant factor in patients attending a liver clinic in Australia. Although newer therapies for hepatitis C may be interferon-free, the high load of mental illness in patients with HCV needs to be considered. The colocation of psychiatric services with hepatology clinics would likely improve patient care.

4．パーキンソン病とうつ

The frequency of depression in patients with Parkinson's disease is approximately 30-40%. Depression has a significantly negative impact on the QOL in Parkinson's disease patients. It leads to the worsening of tremors and frozen gait without disease progression and decreases the patient's motivation to participate in rehabilitation. The distinguishing feature of depression in patients with Parkinson's disease is that guilt, self-blame and suicidal ideation are rarely seen compared to that observed in patients with major depression. Depression can occur in the pre-motor, diagnostic and advanced stages of Parkinson's disease. In particular, patients with wearing-off symptoms are apt to develop anxiety. As for treatment, it is very important to optimize dopamine replacement therapy. Antiparkinsonian drugs may have beneficial effects not only on the motor symptoms of the disease, but also the patient's mood. Cognitive behavioral therapy (CBT) and peer counseling may also be beneficial.

Systemic Autoimmune Diseases and Depressive Disorders

IntroductionThe incidence of depression accompanying medical pathologies is elevated and has prognostic importance. ObjectivesTo determine the frequency of depression in patients with systemic autoimmune diseases (SAD), as well as to determine the frequency of pain, fatigue and sleep disorders in these patients and their relation with depression. Material and methodsWe performed a descriptive, prospective study on 88 patients with AID. The CES-D depression questionnaire, FSS fatigue questionnaire and the Pittsburgh sleep quality index were administered. Results69% (n=61) of patients were depressed. Pain was found in 97% (59/61) of depressed patients and in 62% (17/27) of non-depressed patients (P=.0006). Sleep disorders were found in 95% of depressed patients, whereas 60% of non-depressed patients presented them (P=.00008). Depression was associated with fatigue: 80% (49/61) for depressed and 44% for non-depressed (P=.001) persons. DiscussionA very elevated prevalence of depression was found in SAD: 69%; constituting the most frequent comorbidity. Depression was significantly associated with pain, fatigue and sleep disorders.

Enfermedades autoinmunitarias sistémicas y trastornos depresivos

Introduction The incidence of depression accompanying medical pathologies is elevated and have prognostic importance. Objective To determine the frequency of depression in patients with systemic autoimmune diseases (SAD), as well as to determine the frequency of pain, fatigue and sleep disorders in these patients and their relation with depression. Material and methods We performed a descriptive, prospective study on 88 patients with AID. The CES-D depression questionnaire, FSS fatigue questionnaire and the Pittsburgh sleep quality index were administered. Results 69% (n = 61) of patients were depressed. Pain was found in 97% (59/61) of depressed patients and in 62% (17/27) of non-depressed patients ( P = .0006). Sleep disorders were found in 95% of depressed patients, whereas 60% of non-depressed patients presented them ( P = .00008). Depression was associated with fatigue: 80% (49/61) for depressed and 44% for non-depressed (p = 0,001) persons. Discussion A very elevated prevalence of depression was found in SAD: 69%; constituting the most frequent comorbidity. Depression was significantly associated with pain, fatigue and sleep disorders.

Post-Stroke and Clinically-Defined Vascular Depression in Geriatric Rehabilitation Patients

The authors examined the vascular depression hypothesis by comparing the frequency of post-stroke depression and clinically-defined vascular depression and by examining the relationship between vascular burden and depression. Data from 670 geriatric rehabilitation patients were incorporated to compare the frequency of depression in three patient groups: 1) those with no evidence of vascular disease or stroke, 2) those with cerebrovascular risk factors (CVRFs) but no evidence of stroke, and 3) patients with stroke. They examined the unique relationship between CVRFs and depression by use of logistic-regression analysis. Although the frequency of depression was not significantly different between stroke (36.4%), CVRF (35.2%), and non-vascular patients (28.7%), there was a significant increase in the frequency of depression in patients without stroke as CVRF burden increased. This effect was not observed among stroke patients. CVRF burden predicted depression among patients without stroke even after controlling for general medical comorbidity, cognitive functioning, and ADL limitations. These findings provide empirical support for the vascular depression hypothesis and also indicate that the rates of clinically-defined vascular depression and post-stroke depression are similar in geriatric rehabilitation patients.

Somatic symptoms and depression in general practice in Italy

Among primary care attenders, depression is a common and debilitating disturbance. These patients imply higher medical costs compared with those without depression, even after controlling for comorbid physical illness. A study performed in 15 countries worldwide has shown that ICD-10 mental disorders were present in 24% of primary care attenders. Detection and management of depression in primary care have received increasing attention. Most individuals with depression have been shown to consult their GPs for somatic symptoms rather than psychological ones. In the study mentioned above, 69% of the depressed patients reported only somatic symptoms. Another study found that GPs were able to diagnose a mental disorder in 90% of subjects presenting psychopathological symptoms and in 50% of those with somatic symptoms. In the light of the above, the Italian College of General Practitioners (Società Italiana di Medicina Generale-SIMG) in the area of Varese (north of Italy) organised a course on depression. Then a study was carried out in our setting. The aim was to evaluate the frequency of depression in patients who seek care for somatic symptoms, where tests showed that these symptoms were without an organic cause.

Evaluation of the frequency of depression in patients with endometriosis and pelvic pain

Evaluate the frequency of depression in women with endometriosis and actual symptom of pelvic pain to determine the necessity of psychological support. A total of 50 women aged 24 to 48 with endometriosis and referring pelvic pain. The prevalence of depression was evaluated by Beck's Depression Inventory adapted to the Brazilian population. It was found that 92% of the subjects presented depressive symptoms, being 56% from moderate to high levels. Although 66% of the women were using hormonal medication to treat endometriosis, there was no significant correlation between the presence of depression and the use of these medications. The results showed a high prevalence of depression symptoms in these patients confirming the necessity of psychological support.

Risk Factors Associated with Depression in Patients with Type 2 Diabetes Mellitus

Background This study was undertaken in order to identify the prevalence and factors associated with depression in a group of patients with type 2 diabetes mellitus. Methods Our design consisted of a cross-sectional study at the Department of Neurology and Psychiatry of the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán in Mexico City. Study units included 189 patients with type 2 diabetes mellitus (DM). Beck Depression Inventory scale was used to measure the presence of depression, while the independent variables evaluated to explain depression were sociodemographic (gender, marital status, religion, education, occupation, socioeconomic status) and characteristics of the disease were disease duration, comorbidity, compliance, and glycemic control. Results Prevalence of depression was 39% (74 patients). The following risk factors were identified by univariate analysis: being widowed (OR 3.54, confidence interval [CI] 1.56–8.11, p = 0.0007); female (OR 2.95, CI 1.50–5.82, p = 0.006); housewife (OR 2.08, CI 1.10–3.94, p = 0.01); poor compliance (OR 2.14, CI 1.12–4.10, p = 0.01), and presence of comorbidity (OR 5.60, CI 1.51–24.5, p = 0.002). On the other hand, the most constant associations were presence of blood glucose at the last appointment ≥200 (OR 3.23, CI 1.59–6.60, p = 0.0003) and ≥250 (OR 2.15, CI 0.93–5.03, p = 0.05), as the average of the last five blood glucoses ≥200 (OR 3.67, CI 1.76–7.73, p = 0.0001), ≥250 (OR 4.07, CI 1.61–10.49, p = 0.0007) and ≥300 (OR 2.12, CI 1.48–3.02, p = 0.003). Discriminant function analysis of the variables, previously studied in univariate analysis, was carried out for the presence of depression. A stepwise model included the following variables: average of the last five blood glucoses; 2) widowed or divorced, and 3) female. Conclusions Frequency of depression in patients with type 2 DM was high (39%). High level of blood glucose stands out as a variable associated with presence of depression. Other associations were presence of comorbidity, being a female, and being widowed or divorced.

COMPARISON OF FLUPIRTINE MALEATE AND DIHYDROCODEINE IN PATIENTS FOLLOWING SURGERY

Flupirtine maleate 100 mg was compared with dihydrocodeine 60 mg when given by mouth to 50 women on the first 3 days following abdominal hysterectomy in a double-blind parallel-group trial. The analgesia produced was similar for both preparations, and the consumption of active drug was the same in both groups. The only significant differences in side-effects were an increased frequency of depression in patients receiving flupirtine and of sleepiness in those receiving dihydrocodeine.

Irritable colon and depression

Numerous attempts have been made to relate specific emotional conflicts to colonic symptoms in the irritable colon syndrome. Depression has been described as an accompaniment of the illness. This paper investigates the relationship between irritable colon and depression using self-rating symptom scales and the Zung Self-Rating Depression Scale. Thirty-one subjects were followed for two months in a double-blind study employing a tricyclic antidepressant and an inactive placebo. The study demonstrates the frequency of depression in patients with the syndrome; it shows a clearly positive treatment effect with placebo alone for both depressive symptoms and gastrointestinal complaints, and suggests that tricyclic antidepressant therapy results in moderately greater improvement in symptoms than does treatment with placebo alone.